The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis

Abstract Background We aimed to explore the causal relationship between blood metabolites and the risk of visceral obesity, as measured by visceral adipose tissue (VAT). Methods Summary statistics for 486 blood metabolites and total, as well as sex-stratified, MRI-derived VAT measurements, adjusted...

Full description

Bibliographic Details
Main Authors: Zhaoxiang Wang, Qichao Yang
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-024-02035-x
_version_ 1797273410948038656
author Zhaoxiang Wang
Qichao Yang
author_facet Zhaoxiang Wang
Qichao Yang
author_sort Zhaoxiang Wang
collection DOAJ
description Abstract Background We aimed to explore the causal relationship between blood metabolites and the risk of visceral obesity, as measured by visceral adipose tissue (VAT). Methods Summary statistics for 486 blood metabolites and total, as well as sex-stratified, MRI-derived VAT measurements, adjusted for body mass index (BMI) and height, were collected from previous genome-wide association studies (GWAS). A two-sample Mendelian Randomization (MR) design was used. Comprehensive evaluation was further conducted, including sensitivity analysis, linkage disequilibrium score (LDSC) regression, Steiger test, and metabolic pathway analysis. Results After multiple testing correction, arachidonate (20:4n6) has been implicated in VAT accumulation (β = 0.35, 95%CI:0.18–0.52, P < 0.001; FDR = 0.025). Additionally, several blood metabolites were identified as potentially having causal relationship (FDR < 0.10). Among them, lysine (β = 0.67, 95%CI: 0.28–1.06, P < 0.001; FDR = 0.074), proline (β = 0.30, 95%CI:0.13–0.48, P < 0.001; FDR = 0.082), valerate (β = 0.50, 95%CI:0.23–0.78, P < 0.001, FDR = 0.091) are associated with an increased risk of VAT accumulation. On the other hand, glycine (β=-0.21, 95%CI: -0.33–0.09), P < 0.001, FDR = 0.076) have a protective effect against VAT accumulation. Most blood metabolites showed consistent trends between different sexes. Multivariable MR analysis demonstrated the effect of genetically predicted arachidonate (20:4n6) and proline on VAT remained after accounting for BMI and glycated hemoglobin (HbA1c). There is no evidence of heterogeneity, pleiotropy, and reverse causality. Conclusion Our MR findings suggest that these metabolites may serve as biomarkers, as well as for future mechanistic exploration and drug target selection of visceral obesity.
first_indexed 2024-03-07T14:43:58Z
format Article
id doaj.art-b8fd6b2e13ad49cba202b68ec204ea40
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-03-07T14:43:58Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-b8fd6b2e13ad49cba202b68ec204ea402024-03-05T20:08:02ZengBMCLipids in Health and Disease1476-511X2024-02-0123111110.1186/s12944-024-02035-xThe causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysisZhaoxiang Wang0Qichao Yang1Department of Endocrinology, Affiliated Kunshan Hospital of Jiangsu UniversityDepartment of Endocrinology, Affiliated Wujin Hospital of Jiangsu UniversityAbstract Background We aimed to explore the causal relationship between blood metabolites and the risk of visceral obesity, as measured by visceral adipose tissue (VAT). Methods Summary statistics for 486 blood metabolites and total, as well as sex-stratified, MRI-derived VAT measurements, adjusted for body mass index (BMI) and height, were collected from previous genome-wide association studies (GWAS). A two-sample Mendelian Randomization (MR) design was used. Comprehensive evaluation was further conducted, including sensitivity analysis, linkage disequilibrium score (LDSC) regression, Steiger test, and metabolic pathway analysis. Results After multiple testing correction, arachidonate (20:4n6) has been implicated in VAT accumulation (β = 0.35, 95%CI:0.18–0.52, P < 0.001; FDR = 0.025). Additionally, several blood metabolites were identified as potentially having causal relationship (FDR < 0.10). Among them, lysine (β = 0.67, 95%CI: 0.28–1.06, P < 0.001; FDR = 0.074), proline (β = 0.30, 95%CI:0.13–0.48, P < 0.001; FDR = 0.082), valerate (β = 0.50, 95%CI:0.23–0.78, P < 0.001, FDR = 0.091) are associated with an increased risk of VAT accumulation. On the other hand, glycine (β=-0.21, 95%CI: -0.33–0.09), P < 0.001, FDR = 0.076) have a protective effect against VAT accumulation. Most blood metabolites showed consistent trends between different sexes. Multivariable MR analysis demonstrated the effect of genetically predicted arachidonate (20:4n6) and proline on VAT remained after accounting for BMI and glycated hemoglobin (HbA1c). There is no evidence of heterogeneity, pleiotropy, and reverse causality. Conclusion Our MR findings suggest that these metabolites may serve as biomarkers, as well as for future mechanistic exploration and drug target selection of visceral obesity.https://doi.org/10.1186/s12944-024-02035-xVisceral obesityBlood metabolitesGWASLDSCMendelian randomization analysis
spellingShingle Zhaoxiang Wang
Qichao Yang
The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
Lipids in Health and Disease
Visceral obesity
Blood metabolites
GWAS
LDSC
Mendelian randomization analysis
title The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
title_full The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
title_fullStr The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
title_full_unstemmed The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
title_short The causal relationship between human blood metabolites and the risk of visceral obesity: a mendelian randomization analysis
title_sort causal relationship between human blood metabolites and the risk of visceral obesity a mendelian randomization analysis
topic Visceral obesity
Blood metabolites
GWAS
LDSC
Mendelian randomization analysis
url https://doi.org/10.1186/s12944-024-02035-x
work_keys_str_mv AT zhaoxiangwang thecausalrelationshipbetweenhumanbloodmetabolitesandtheriskofvisceralobesityamendelianrandomizationanalysis
AT qichaoyang thecausalrelationshipbetweenhumanbloodmetabolitesandtheriskofvisceralobesityamendelianrandomizationanalysis
AT zhaoxiangwang causalrelationshipbetweenhumanbloodmetabolitesandtheriskofvisceralobesityamendelianrandomizationanalysis
AT qichaoyang causalrelationshipbetweenhumanbloodmetabolitesandtheriskofvisceralobesityamendelianrandomizationanalysis